Despite extensive glycemic control, macrovascular complications remain significant in type 1 diabetes, indicating other factors may be to blame.
Read More »Caution for Using SGLT-2 Inhibitors in Type 1 Diabetes: ADA
There is currently a huge unmet need for non-insulin add on therapy in type 1 diabetes, but are SGLT inhibitors the right drug for the job?
Read More »Better Outcomes with Intensive Control of BP, Adiposity and Lipids Than A1c
It has been known for so long that optimal glycemic control in type 1 diabetes can decrease the risk of micro and macrovascular complications, but why is the risk still high despite intensive glycemic control?
Read More »Rotavirus Vaccination A Practical Measure to Prevent Type 1 Diabetes
If environmental factors such as enteroviruses can trigger beta-cell autoimmunity, then is it possible that a vaccine can reduce the likelihood of developing type 1 diabetes?
Read More »Development of Heart Disease in Young Adults with Type 1 Diabetes — ADA 2019
Could older recommendations of maintaining a blood pressure of 140/90 mmHg be misleading in younger adults with type 1 diabetes for cardiovascular risk reduction?
Read More »The Association Between Cardiac Autonomic Dysfunction and Impaired Myocardial Blood Flow Regulation — ADA
Myocardial flow reserve plays a significant role as a predictor of cardiac death in patients with diabetes.
Read More »New Recommendations for Time In Range Goals Using A CGM — ADA 2019
The use of continuous glucose monitoring expanding into clinical practice.
Read More »Immunomodulation Delays Onset of Type 1 Diabetes — ADA 2019
TrialNet research reveals the benefits of Teplizumab in delaying clinical type 1 diabetes in people at high risk.
Read More »Why Low Carb Diets for Type 1 Patients?
Why patients with type 1 diabetes are more likely to spend time in hypoglycemia.
Read More »Lower BMI for Type 1 Patients Improves CVD Outcomes
Obesity has been a leading cause of mortality and morbidity of cardiovascular disease.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.